Eli Lilly ( LLY 1.19%) and Novo Nordisk ( NVO 2.44%) are two of the leading companies in the fast-growing GLP-1 weight loss ...
Eli Lilly (LLY) stock is in focus as the company posts late-stage trial data to indicate that its obesity pill orforglipron ...
The City of Huntsville has taken another step toward bringing pharmaceutical giant Eli Lilly's $6 billion facility to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback